The Iliac/SFA/Popliteal Center

Filter Your Results




A Tale of Two Legs: Putting Patients Ahead by Leaving Nothing Behind

Gregory A. Stanley, MD

April 2017—With the widespread use of various endovascular technologies for lower extremity revascularization, it is only appropriate that interventionists have a fundamental understandi…

An Interview With Antonio Micari, MD, PhD

April 2017—Dr. Micari discusses his protocols in Italy for treating femoropopliteal ISR, the use of bioresorbable scaffolds below the knee, and the next generation of devices in these disease settings.

A Proposal for Standardizing Restenosis Patterns of Femoropopliteal Artery Disease

Lawrence A. Garcia, MD

March 2017—Peripheral artery disease is a common disorder, affecting over 200 million people worldwide.1 Within this context, the femoropopliteal artery remains a common culprit of lifes…

Building a Comprehensive CLI Program

J.A. Mustapha, MD; Larry J. Diaz-Sandoval, MD; Mike Sumners, DO; and Fadi Saab, MD

January 2017—The multitasking, multidisciplinary team approach to addressing this multilevel disease.

Taking on Complex SFA Disease

With Peter Goverde, MD

November 2016—Esteemed vascular surgeon Peter Goverde discusses how interventionists should approach increasingly difficult clinical presentations.

Comparative Analysis and Critical Components of Drug-Coated Balloons

With Juan F. Granada, MD, FACC; Manasi Ramachandran, PhD; and Michael S. Owens, PhD

November 2016—Comparative Analysis of Drug-Coated Balloons BY JUAN F. GRANADA, MD, FACC Drug-coated balloons (DCBs) are rapidly becoming the leading strategy for the treatment of …

Understanding Clinical Data and Its Application to Clinical Practice

Krishna Rocha-Singh, MD

November 2016—The emphasis on evidence-based medical practice emerged in response to the potential hazards and inconsistencies of empirical clinical decision making and reinforced the impor…

Complexity of SFA Disease Is Driving the Need for Dual Therapy

Prof. Thomas Zeller, MD

October 2016—A discussion of potential differential indications for drug-eluting devices.



2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.